SEC Form 4 · accession 0001583742-16-000002
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nasrat A Hakim
Officer — CEO & President · Director · 10% Owner
Period of report
Aug 17, 2016
Accepted (ET)
Aug 19, 2016 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 17, 2016 | M | 142,857,143 | $0.00 | A | 142,971,097 | I | see footnote |
| Common Stock | holding | — | — | — | 21,926,793 | D | ||
| Common Stock | holding | — | — | — | 2,700,000 | I | by IRA of Nasrat Hakim |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series I Convertible Preferred SharesF1,F2,F3 | $0.00 | Aug 17, 2016 | M | 100 | D | Feb 7, 2014 | — | Common Stock | 142,857,143 | 0 | I |
Explanation of responses
- F1The preferred shares are convertible into shares of common stock at a rate of 1,428,571.43 shares of common stock for each whole share of preferred stock.
- F2The securities are held by Mikah Pharma LLC. Nasrat Hakim is the sole beneficial owner of Mikah Pharma LLC.
- F3None